Does BELIMUMAB Cause Pulmonary hypertension? 20 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Pulmonary hypertension have been filed in association with BELIMUMAB (BENLYSTA). This represents 0.1% of all adverse event reports for BELIMUMAB.
20
Reports of Pulmonary hypertension with BELIMUMAB
0.1%
of all BELIMUMAB reports
3
Deaths
11
Hospitalizations
How Dangerous Is Pulmonary hypertension From BELIMUMAB?
Of the 20 reports, 3 (15.0%) resulted in death, 11 (55.0%) required hospitalization.
Is Pulmonary hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELIMUMAB. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does BELIMUMAB Cause?
Product dose omission issue (4,671)
Systemic lupus erythematosus (3,388)
Fatigue (1,650)
Drug ineffective (1,570)
Pain (1,510)
Wrong technique in device usage process (1,347)
Injection site pain (1,279)
Malaise (1,257)
Headache (1,207)
Arthralgia (1,114)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
MACITENTAN (1,505)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
Which BELIMUMAB Alternatives Have Lower Pulmonary hypertension Risk?
BELIMUMAB vs BELINOSTAT
BELIMUMAB vs BELUMOSUDIL
BELIMUMAB vs BELVIQ
BELIMUMAB vs BELZUTIFAN
BELIMUMAB vs BEMPEDOIC ACID